MaxWell Biosystems exhibited MaxOne with its newly developed data acquisition unit at the SelectBio Advances in Drug Discovery Conference in Hinxton, Cambridge, UK. It was an exciting meeting, attended by many researchers who are currently screening for efficacy and toxicity using iPS cell lines or developing enabling techniques and technologies for this. Progress in stem cell biology is revolutionizing drug discovery research now; the ability to grow and differentiate stem cell lines is providing a far more relevant model for pre-clinical testing. The challenges in assay development, scale up and quality control were discussed at this event.
In addition, the MxW’ers attending the event enjoyed the beautiful Wellcome Genome Campus, with its Georgian Hall, green scenery and modern conference center.